The progress of Arizona’s bioscience sector is chronicled in annual reports from the Flinn Foundation that track key developments and the latest data on performance measures like jobs, wages, research funding, and risk capital. The reports dating back to to 2014 are found below. Earlier reports—going back to 2003—are available on the First Decade page.
Current Progress Report
The COVID-19 pandemic brought unspeakable suffering to Arizona, but also brought forth the best from the state’s responsive bioscience sector, as researchers, companies, and health-care leaders made significant contributions to help us navigate 2020. To learn more about the past year’s developments and accomplishments, dive into the Latest Progress of the Biosciences in Arizona. And watch the 2021 Flinn Foundation event.
Progress
For the biosciences in Arizona, 2019 was almost entirely good news. The state’s research enterprise performed better than ever, with all-time highs for National Institutes of Health funding and university R&D. Tech transfer was looking up. Risk capital set a record. And bioscience jobs and wages continued to grow faster than the private sector as a whole. But as 2020 began, a global crisis loomed.
Progress
This 8-page brochure illustrates the importance of the robust bioscience ecosystem here in Arizona and how Arizona’s Bioscience Roadmap Steering Committee is advancing and accelerating this critical ecosystem. The brochure also highlights the advances made in the state’s bioscience sector during 2018 in areas such as entrepreneurism, venture capital, industry, research, education, and clinical care.
Progress
Arizona’s bioscience sector is adding jobs at a rate outpacing the biosciences nationally and the state’s overall private sector, while the state’s public universities are seeing increases in bioscience research funding, expenditures and tech transfer, according to the new data. However, there was a decline in bioscience venture capital over the past two years.
Progress
The year 2016 was highlighted by a $43 million precision-medicine research grant for University of Arizona, TGen’s affiliation with City of Hope and planned Phoenix expansion, the announcement of the Mayo Clinic School of Medicine in partnership with Arizona State University, and the unveiling of plans for a new biotech campus along Tempe Town Lake.
Progress
The state’s bioscience industry continues its strong job and wage growth and had its best venture capital year since 2011, according to the new data. While bio-related university startups continued to increase, there were declines in research dollars and expenditures.
Progress
The year 2014 was highlighted by the merger of Banner Health with the University of Arizona Health Network, construction on the Phoenix Biomedical Campus, progress in planning the Arizona Bioscience Corridor in northeast Phoenix, and the launch of the updated Arizona’s Bioscience Roadmap.
